Related Experiment Video
Updated: Jul 5, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation
Shashwati Basak1, Suzanne B R Jacobs, Adam J Krieg
1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Abstract:
The p53 tumor suppressor restricts tumorigenesis through the transcriptional activation of target genes involved in cell-cycle arrest and apoptosis. Here, we identify Prl-3 (phosphatase of regenerating liver-3) as a p53-inducible gene. Whereas previous studies implicated Prl-3 in metastasis because of its overexpression in metastatic human colorectal cancer and its ability to promote invasiveness and motility, we demonstrate here that Prl-3 is an important cell-cycle regulator. Consistent with a role in DNA damage-induced cell-cycle arrest, Prl-3 overexpression induces G(1) arrest downstream of p53 by triggering a PI3K-Akt-activated negative feedback loop. Surprisingly, attenuation of Prl-3 expression also elicits an arrest response, suggesting that basal level Prl-3 expression is pivotal for normal cell-cycle progression. Our findings highlight key dose-dependent functions of Prl-3 in both positive and negative regulation of cell-cycle progression and provide insight into Prl-3's role in cancer progression.
Insights
Prl-3, a gene induced by the tumor suppressor p53, acts as a crucial cell-cycle regulator. Its dual role in cell-cycle progression and cancer progression offers new therapeutic insights.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The p53 tumor suppressor is critical in preventing cancer by regulating genes for cell-cycle arrest and apoptosis.
- Prl-3 (phosphatase of regenerating liver-3) has been linked to cancer metastasis due to its overexpression in colorectal cancer and promotion of cell invasiveness.
Purpose of the Study:
- To identify Prl-3 as a p53-inducible gene.
- To elucidate the role of Prl-3 in cell-cycle regulation and cancer progression, beyond its previously known role in metastasis.
Main Methods:
- Identification of Prl-3 as a p53 target gene.
- Investigation of Prl-3's function in cell-cycle regulation through overexpression and attenuation studies.
- Analysis of signaling pathways involved, including PI3K-Akt.
Main Results:
- Prl-3 is confirmed as a p53-inducible gene.
- Prl-3 overexpression induces G1 cell-cycle arrest downstream of p53, mediated by a PI3K-Akt feedback loop.
- Reduced Prl-3 expression also causes cell-cycle arrest, indicating its importance in normal cell-cycle progression.
Conclusions:
- Prl-3 exhibits dose-dependent functions in regulating cell-cycle progression, acting as both a positive and negative regulator.
- These findings reveal novel insights into Prl-3's multifaceted role in cancer development and progression.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
Positive Regulator Molecules